Skip to content

The Effects Of Brain Stimulation On Balance Control In Parkinson's Disease

The Effects Of Transcranial Direct Current Stimulation (tDCS) On Balance Control In Parkinson's Disease (PD)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12620000148976
Enrollment
50
Registered
2020-02-12
Start date
2018-02-01
Completion date
2018-08-10
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Parkinson’s disease (PD) is a degenerative disease of the central nervous system. When asked to perform motor and cognitive tasks at the same time, stance control can deteriorate further. Transcranial Direct Current Stimulation (tDCS) can be used to safely regulate the excitability of brain without serious adverse effects. It has been employed to improve executive function, attention and working memory in healthy older people and has been shown have potential benefits for people with PD. Functional near infra-red spectroscopy (fNIRS) as a non-invasive functional neuroimaging technique, has been used in brain research through measuring changes on blood circulation in a specific brain region. The purpose of this study is to investigate the effects of tDCS on dual task performance in people with Parkinson’s disease, and to evaluate alternation of blood circulation changes induced by tDCS.

Interventions

A constant transcranial direct current stimulation (tDCS) is delivered using a battery-driven stimulator (DC-StimulatorPlusTM, NeuroConn, Ilmenau, Germany) with anodal (5 × 7 cm2), and cathodal (10 × 10 cm2) water-soaked sponge electrodes with an intensity of 1 mA during 20 min over 4 sessions. The anode electrode is placed over the left dorsolateral prefrontal cortex (LDLPFC), corresponding to F3 in the 10-20 EEG system. The cathode electrode is placed over the right orbitofrontal cortex. Two s

A constant transcranial direct current stimulation (tDCS) is delivered using a battery-driven stimulator (DC-StimulatorPlusTM, NeuroConn, Ilmenau, Germany) with anodal (5 × 7 cm2), and cathodal (10 × 10 cm2) water-soaked sponge electrodes with an intensity of 1 mA during 20 min over 4 sessions. The anode electrode is placed over the left dorsolateral prefrontal cortex (LDLPFC), corresponding to F3 in the 10-20 EEG system. The cathode electrode is placed over the right orbitofrontal cortex. Two straps is used to affix the electrodes. A fitted head cap (Artinis Medical Systems, The Netherlands) is applied to keep the electrodes in place and to assure that the electrodes have full contact to the scalp. This method of LDLPFC localization has been used before in several tDCS studies on cognitive function, and motor function, which has been regarded as a relatively accurate method of localization by neuroimaging techniques. For real stimulation, constant current is increased to 1 mA in a ramp-like fashion over 15 seconds, holds constant at 1 mA for 19 mins and 30 seconds, and then decreases over 15 seconds. Sham stimulation included 15 seconds of ramping the stimulation up to 1 mA and then immediately down again at the beginning and the end of intervention; this is to control for the participants physical sense of stimulation associated with current changes. This design is a reliable control as sensations resulting from tDCS become negligible after the initial minute of stimulation. The tDCS intervention is administered by a PhD candidate. Each participant attends four sessions, which including real tDCS with firm standing, real tDCS with foam standing, sham tDCS with firm standing and sham tDCS with foam standing. Under the firm standing condition, participants are instructed to stand directly on the platform with both feet hip width apart and focus on their balance. When participants under the foam standing, they are demonstrated to position themselves in the centre of medium density foam block (74.5cm x 62cm x 15.7cm) (Qiu, Cole et al. 2013). In order to monitor fidelity to the intervention, another investigator is onsite during the tDCS stimulation. Prior to the tDCS stimulation, participants are informed the study protocol. Participants are allowed to inform investigator if they need extra rest or are willing to stop from participating during each session. The study has been designed as a cross over study and the interval between tDCS sessions is seven days, as this interval has been used in previous tDCS studies to effectively wash out any potential after effects (Fregni, Boggio et al. 2005, Fregni, Gimenes et al. 2006, Vanderhasselt, De Raedt et al. 2013).

Sponsors

Queensland University of Technology
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1) Be naturally right handed. 2) Be reasonably fluent in English. 3) Have normal or corrected-to normal vision, and without hearing problems. 4) Have no previous brain surgery, have no implants to your head (cochlear implants, aneurysm clips, brain electrodes). 5) Live independently in the community, and to be able to walk independently without the use of aids. Additionally, potential participants have Parkinson's disease should also meet the following inclusion criteria: 1) Have to be diagnosed with PD but no other neurological disorder. 2) Have to have a Hoehn & Yahr (H&Y) score less than or equal to 3. 3) Have to be able to ambulate without assistance. 4) Doesn't have surgical treatment for Parkinson’s disease (DBS).

Exclusion criteria

1) Recent history of cardio-vascular problems. 2) Significant cognitive impairment.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026